Kaise Mitsuru, Kimura Ryusuke, Nomura Kosuke, Kuribayashi Yasutaka, Kikuchi Daisuke, Iizuka Toshiro, Ohkura Yasuo
Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
Department of Pathology, Kyorin University School of Medicine, Tokyo, Japan.
Endoscopy. 2014 Oct;46(10):827-32. doi: 10.1055/s-0034-1377524. Epub 2014 Jul 18.
High-grade atypia demonstrated by endocytoscopy may be a key criterion for the diagnosis of gastric cancer. We therefore sought to verify whether endocytoscopic atypia can provide satisfactory levels of diagnostic accuracy and concordance among trainee and expert endoscopists.
A total of 100 lesions evaluated by endocytoscopy and histopathology were enrolled to create an endocytoscopic image catalog (44 early cancers, 10 low-grade adenomas, 46 non-neoplastic lesions). Four endoscopists (two trainees and two experts) independently reviewed the catalog images and evaluated each of them for the presence or absence of endocytoscopic atypia. High-grade endocytoscopic atypia, as a criterion for cancer diagnosis, was defined as the consistent observation of any of the following features: lumen absence, lumen fusion, and irregular nuclei showing the three typical features (heterogeneous shape, swelling, and disarrangement).
High-grade endocytoscopic atypia was observed in 78 %, 18 %, and 4 % of cancers, adenomas, and non-neoplastic lesions, respectively. The sensitivity, specificity, accuracy, and positive and negative predictive values for cancer diagnosis by endocytoscopy were 78.4 %, 93.3 %, 87.3 %, 85.4 %, and 87.3 %, respectively. The concordance rate for the results of high-grade endocytoscopic atypia was good among the four endoscopists (κ value 0.682). No significant difference in diagnostic accuracy or concordance was observed between trainee and expert endoscopists.
Using the defined high-grade atypia as a diagnostic criterion of cancer, endocytoscopy provided a satisfactory level of accuracy and concordance for the diagnosis of early gastric cancer, regardless of endoscopic expertise.
内镜下细胞检查显示的高级别异型增生可能是胃癌诊断的关键标准。因此,我们试图验证内镜下细胞异型增生能否在实习内镜医师和专家内镜医师中提供令人满意的诊断准确性和一致性。
总共纳入100个经内镜下细胞检查和组织病理学评估的病变,建立一个内镜下细胞图像目录(44例早期癌、10例低级别腺瘤、46例非肿瘤性病变)。四位内镜医师(两名实习医师和两名专家)独立查看目录图像,并评估每个图像是否存在内镜下细胞异型增生。将高级别内镜下细胞异型增生定义为一致观察到以下任何特征,以此作为癌症诊断标准:无管腔、管腔融合以及显示三种典型特征(形状不均一、肿胀和排列紊乱)的不规则细胞核。
分别在78%、18%和4%的癌、腺瘤和非肿瘤性病变中观察到高级别内镜下细胞异型增生。内镜下细胞检查诊断癌症的敏感性、特异性、准确性以及阳性和阴性预测值分别为78.4%、93.3%、87.3%、85.4%和87.3%。四位内镜医师之间高级别内镜下细胞异型增生结果的一致性良好(κ值为0.682)。实习内镜医师和专家内镜医师之间在诊断准确性或一致性方面未观察到显著差异。
以内镜下定义的高级别异型增生作为癌症诊断标准,无论内镜专业水平如何,内镜下细胞检查对早期胃癌的诊断都具有令人满意的准确性和一致性。